Litcius/Paper detail

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV

Mohammad Ali Sahraian, Fereshteh Ghadiri, Amirreza Azimi, Abdorreza Naser Moghadasi

2021Vaccine34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectMalaiseMultiple sclerosisShiveringVaccinationInternal medicinePediatricsImmunologySurgerySARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesVirology and Viral Diseases
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV | Litcius